StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ARWR Arrowhead Pharmaceuticals | $74.45 | +1.74% | — | — | — | — | — | 53 |
| 1 | NVO Novo Nordisk | $44.94 | +1.48% | — | — | — | — | — | 72 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $47.36 |
| +3.59% |
| — |
| — |
| — |
| — |
| — |
| 72 |
| 3 | REGN Regeneron | $642.72 | +1.97% | — | — | — | — | — | 61 |
| 4 | AMGN Amgen | $328.97 | -0.54% | — | — | — | — | — | 55 |
| 5 | LLY Eli Lilly | $1023.33 | +0.19% | — | — | — | — | — | 54 |
| 6 | BNTX BioNTech | $89.66 | +2.13% | — | — | — | — | — | 53 |
| 7 | TEM Tempus AI | $45.54 | +0.02% | — | — | — | — | — | 48 |
| 8 | VRTX Vertex Pharma | $432.47 | -0.42% | — | — | — | — | — | 46 |
| 9 | GILD Gilead Sciences | $130.42 | -0.06% | — | — | — | — | — | 40 |